Related Experiment Video

Updated: Jun 13, 2026

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

Acute coronary syndrome in the patient with diabetes: is the management different?

Amit P Amin1, Steven P Marso

  • 1Saint Luke's Mid America Heart Institute, 4401 Wornall Road, Kansas City, MO 64111, USA.

Current Cardiology Reports
|May 7, 2010
PubMed

Insights

Diabetic patients with acute coronary syndrome (ACS) benefit significantly from advanced antiplatelet therapies and aggressive revascularization strategies. Early intervention with treatments like prasugrel and drug-eluting stents improves outcomes and reduces restenosis risk.

Area of Science:

  • Cardiology
  • Endocrinology
  • Pharmacology

Background:

  • Diabetic patients with acute coronary syndrome (ACS) face worse prognoses due to heightened platelet reactivity and disease severity.
  • Established therapies, especially antiplatelet agents, offer greater benefits to diabetic individuals with ACS.

Purpose of the Study:

  • To review current pharmacologic and revascularization strategies for managing diabetic patients experiencing ACS.
  • To highlight the specific benefits of intense P2Y12 inhibition and drug-eluting stents in this high-risk population.

Main Methods:

  • Systematic review of recent clinical data and studies.
  • Analysis of treatment outcomes for diabetic patients with ACS.

Main Results:

  • Intense P2Y12 inhibition with prasugrel shows significant clinical value in diabetic ACS patients without increasing bleeding risk.
  • Drug-eluting stents in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction reduce target vessel revascularization up to 2 years, especially in high-risk diabetic patients.

Conclusions:

  • Diabetic patients with ACS benefit from aggressive revascularization and advanced antiplatelet therapies.
  • Tailored management strategies incorporating prasugrel and drug-eluting stents are crucial for improving outcomes in diabetic ACS patients.

More Related Videos

Improving IV Insulin Administration in a Community Hospital12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Related Concept Videos

Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...